Maxcyte (MXCT) Cash from Financing Activities (2020 - 2026)

Maxcyte has reported Cash from Financing Activities over the past 6 years, most recently at $105000.0 for Q4 2025.

  • Quarterly Cash from Financing Activities fell 74.51% to $105000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $656000.0 through Dec 2025, down 68.09% year-over-year, with the annual reading at $656000.0 for FY2025, 68.09% down from the prior year.
  • Cash from Financing Activities was $105000.0 for Q4 2025 at Maxcyte, up from $14000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $184.6 million in Q3 2021 and troughed at $14000.0 in Q3 2025.
  • The 5-year median for Cash from Financing Activities is $428200.0 (2022), against an average of $12.1 million.
  • Year-over-year, Cash from Financing Activities skyrocketed 70325.91% in 2021 and then tumbled 99.76% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.2 million in 2021, then increased by 1.52% to $1.2 million in 2022, then tumbled by 59.77% to $493000.0 in 2023, then dropped by 16.43% to $412000.0 in 2024, then tumbled by 74.51% to $105000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Cash from Financing Activities are $105000.0 (Q4 2025), $14000.0 (Q3 2025), and $154000.0 (Q2 2025).